We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Liberty Media Series A
FWONA
$22.5B
| $1.21M | ﹤0.01% |
38,567
+4,367
| +13% | +$131K |
|
1827
AeroVironment
AVAV
$7.56B
| $1.21M | ﹤0.01% |
42,999
+13,579
| +46% | +$363K |
|
|
TRTN
1828
DELISTED
Triton International Limited
TRTN
| $1.2M | ﹤0.01% |
46,623
+2,196
| +5% | +$51K |
|
1829
SunCoke Energy
SXC
$720M
| $1.2M | ﹤0.01% |
134,037
+33,257
| +33% | +$326K |
|
1830
Anika Therapeutics
ANIK
$258M
| $1.2M | ﹤0.01% |
27,624
+8,169
| +42% | +$390K |
|
1831
Kulicke & Soffa
KLIC
$4.67B
| $1.2M | ﹤0.01% |
58,990
+36,033
| +157% | +$693K |
|
1832
TriMas Corp
TRS
$1.43B
| $1.2M | ﹤0.01% |
57,572
+669
| +1% | +$14.7K |
|
|
FARO
1833
DELISTED
Faro Technologies
FARO
| $1.19M | ﹤0.01% |
33,283
+8,513
| +34% | +$310K |
|
1834
Artisan Partners
APAM
$2.79B
| $1.19M | ﹤0.01% |
43,016
+2,387
| +6% | +$68.5K |
|
|
FRED
1835
DELISTED
Fred's Inc
FRED
| $1.19M | ﹤0.01% |
90,530
+18,803
| +26% | +$296K |
|
1836
Etsy
ETSY
$7.75B
| $1.18M | ﹤0.01% |
111,259
+4,248
| +4% | +$49.8K |
|
1837
Stock Yards Bancorp
SYBT
$2.64B
| $1.18M | ﹤0.01% |
29,097
+847
| +3% | +$37.4K |
|
|
FINL
1838
DELISTED
Finish Line
FINL
| $1.18M | ﹤0.01% |
83,041
+18,404
| +28% | +$309K |
|
1839
Smith & Wesson
SWBI
$651M
| $1.18M | ﹤0.01% |
77,555
+2,621
| +3% | +$40K |
|
|
TTSH
1840
DELISTED
Tile Shop Holdings
TTSH
| $1.18M | ﹤0.01% |
61,330
+18,038
| +42% | +$338K |
|
1841
Huron Consulting
HURN
$2.41B
| $1.18M | ﹤0.01% |
28,029
+659
| +2% | +$29.1K |
|
|
MODV
1842
DELISTED
ModivCare
MODV
| $1.18M | ﹤0.01% |
26,538
+6,554
| +33% | +$269K |
|
|
ALDR
1843
DELISTED
Alder Biopharmaceuticals
ALDR
| $1.18M | ﹤0.01% |
56,591
+2,337
| +4% | +$51.7K |
|
1844
DXP Enterprises
DXPE
$2.43B
| $1.18M | ﹤0.01% |
31,060
+9,204
| +42% | +$329K |
|
|
SNR
1845
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $1.17M | ﹤0.01% |
114,524
+7,897
| +7% | +$80.2K |
|
|
DENN
1846
DELISTED
Denny's
DENN
| $1.16M | ﹤0.01% |
94,130
+3,129
| +3% | +$38.9K |
|
1847
Perdoceo Education
PRDO
$1.99B
| $1.16M | ﹤0.01% |
133,576
+33,482
| +33% | +$308K |
|
|
PPBI
1848
DELISTED
Pacific Premier Bancorp
PPBI
| $1.16M | ﹤0.01% |
30,099
+1,019
| +4% | +$39.2K |
|
1849
HealthStream
HSTM
$819M
| $1.16M | ﹤0.01% |
47,780
+13,491
| +39% | +$314K |
|
1850
St. Joe Company
JOE
$3.54B
| $1.16M | ﹤0.01% |
67,894
+235
| +0.3% | +$4.02K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.